External validation of nomogram to predict progression-free survival at 6 months (PFS6) in patients receiving salvage therapy for advanced urothelial carcinoma (UC). Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Sonpavde, Guru
  • Bellmunt, Joaquim
  • Fougeray, Ronan
  • Salhi, Yacine
  • Pond, Gregory

publication date

  • May 20, 2014